BCA-1/CXCL13, Human
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O43927 |
---|---|
Sequence | Val23-Pro109 (accession number: O43927) , expressed with N-terminal His-tag. |
Purity | > 95% as analyzed by SDS-PAGE and HPLC. |
Endotoxin Level | < 0.2 EU/ µg, determined by LAL method. |
Gene ID | 10563 |
---|---|
Other Names | C-X-C motif chemokine 13, Angie, B cell-attracting chemokine 1, BCA-1, B lymphocyte chemoattractant, CXC chemokine BLC, Small-inducible cytokine B13, CXCL13, BCA1, BLC, SCYB13 |
Target Background | B cell-attracting chemokine 1 (BCA-1)/CXCL13, Human |
Name | CXCL13 |
---|---|
Synonyms | BCA1, BLC, SCYB13 |
Function | Chemotactic for B-lymphocytes but not for T-lymphocytes, monocytes and neutrophils. Does not induce calcium release in B- lymphocytes. Binds to BLR1/CXCR5. |
Cellular Location | Secreted. |
Tissue Location | Highest levels in liver, followed by spleen, lymph node, appendix and stomach. Low levels in salivary gland, mammary gland and fetal spleen |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.